Further, hyper-activated PD1/PD-L1 signals in tumor tissues were an independent marker for patient prognosis—ICC patients expressing high levels of PD1/PD-L1 signals had the poorest prognosis among the entire cohort. The gene discussed is PDCD1; the disease is intrahepatic cholangiocarcinoma.